Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Brown Capital Management LLC raised its holdings in shares of Cytek Biosciences by 24.8% during the 2nd quarter.
Cytek Biosciences has a beta of 0.25, indicating that its share price is 75% less volatile than the S&P 500. Comparatively, SeqLL has a beta of 1.53, indicating that its share price is 53% more volatile than the S&P 500.
Source: https://www.etfdailynews.com/2023/04/15/comparing-cytek-biosciences-nasdaqctkb-seqll-nasdaqsql/
Macquarie Group Ltd. bought a new position in shares of Cytek Biosciences in the 4th quarter valued at approximately $10,748,000.